The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Wolverine Drug Ortho Rhode Island The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and FDA Compliance for Peptide Therapy and BPC 157 Holt Law FDA takes first step in possible reversal of ban on some peptides The Washington Post